SCHEMBL196479

SCHEMBL196479

COC(=O)C(Br)c1ccc(S(=O)(=O)Cl)cc1.COC(=O)C(Br)c1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
MEN1 O00255 2/20 0.34
CA2 P00918 4/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33
FBP1 P09467 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185086 0.95 KMT2A (0.40) KMT2AALDH1A1HSD17B10TDP1CYP3A4
SCHEMBL184992 0.89 CA12 (0.40) KMT2AALDH1A1HSD17B10TDP1SLC6A3
SCHEMBL2363042 0.79 PTGS1 (0.55) KMT2APTGS1PTGS2MEN1CA2
SCHEMBL1550706 0.75 ENPP2 (0.42) KMT2ACYP3A4MEN1CA2CA12
SCHEMBL184810 0.75 CA12 (0.43) KMT2AALDH1A1CA2CA12CA1
SCHEMBL184847 0.74 SMN1; SMN2 (0.52) KMT2AALDH1A1MEN1SMN1; SMN2GAA
SCHEMBL661853 0.74 KMT2A (0.48) KMT2APTGS1PTGS2MEN1NPC1
SCHEMBL30474572 0.74 KMT2A (0.48) KMT2APTGS1PTGS2MEN1NPC1
SCHEMBL68152 0.73 KMT2A (0.64) KMT2AALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL319987 0.73 KMT2A (0.64) KMT2AALDH1A1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP disclosed